ARDX

ARDX

ARDX

Letters With This Ticker

Quarter Letter Date Fund Name QTD YTD Tickers Keywords/Themes Theme Commentary Pitches Letter
2024 Q1 May 15, 2024 Appleseed Fund 0.0% 0.0% AER, AGNC, ARDX, BEI.TO, CCJ, CF, DG, EVR, GNK, HLF, HUM, ITRN, MOS, RHHBY, SFM, VFC, WCC Defensive, gold, healthcare, inflation, value AGNC
HUM
2024 Q3 Nov 13, 2024 Appleseed Fund 0.0% 0.0% AER, AGNC, ARDX, CCJ, CF, DG, DLTR, DSX, EL, GRVY, HLF, HUM, MOS, MRC, MSFT, NVDA, SFM, SNV, SRUUF, WLFC commodities, defensives, energy, inflation, Mining, nuclear, uranium, value SRUUF
CCJ

Pitches With This Ticker

Date Pitch Type Author Company Industry Sub Industry Bull / Bear Stock Exchange Keywords Action
Feb 4, 2026 Twitter / X @justfactstruth Ardelyx, Inc. Pharmaceuticals, Biotechnology & Life Sciences Biotechnology Bull NASDAQ biopharma, biotechnology, ESRD, Gastroenterology, Nephrology, Oraltherapy, Phosphate, Reimbursement, TDAPA, XPHOZAH
Aug 13, 2025 Seeking Alpha Terry Chrisomalis Ardelyx, Inc. Health Care Biotechnology Neutral NASDAQ
Aug 13, 2025 Seeking Alpha Stephen Ayers Ardelyx Health Care Biotechnology Bear NASDAQ

BSD Shareholders of ARDX

This report provides a detailed summary of investor holdings for a specified stock ticker, highlighting key metrics such as fund name, total assets under management (AUM), invested value, portfolio weight, and shares owned. It also tracks changes in share ownership during the last quarter, including the percentage of shares bought or sold and the percentage of outstanding shares owned. The data is generated using an API that processes investor holdings and calculates these values for each fund. This report helps investors and analysts monitor the stock positions of major funds, identify investment trends, and assess the influence of large investors on individual stocks.

Filing Date: September 30, 2025
Manager Name Fund Name Fund AUM Invested Value Portfolio Weight Shares Owned Shares Bought / Sold During Quarter % Bought / Sold During Quarter % of Shares Outstanding Owned
No investor data available.